Found: 7
Select item for more details and to access through your institution.
CTBP1 depletion on prostate tumors deregulates miRNA/mRNA expression and impairs cancer progression in metabolic syndrome mice.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 4, p. 1, doi. 10.1038/s41419-019-1535-z
- By:
- Publication type:
- Article
miR-877-5p as a Potential Link between Triple-Negative Breast Cancer Development and Metabolic Syndrome.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 23, p. 16758, doi. 10.3390/ijms242316758
- By:
- Publication type:
- Article
MiR-106b-5p: A Master Regulator of Potential Biomarkers for Breast Cancer Aggressiveness and Prognosis.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 20, p. 11135, doi. 10.3390/ijms222011135
- By:
- Publication type:
- Article
Adipose tissue from metabolic syndrome mice induces an aberrant miRNA signature highly relevant in prostate cancer development.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 11, p. 2868, doi. 10.1002/1878-0261.12788
- By:
- Publication type:
- Article
Hsa-miR-133a-3p, miR-1-3p, GOLPH3 and JUP combination results in a good biomarker to distinguish between prostate cancer and non-prostate cancer patients.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.997457
- By:
- Publication type:
- Article
CTBP1/CYP19A1/estradiol axis together with adipose tissue impacts over prostate cancer growth associated to metabolic syndrome.
- Published in:
- International Journal of Cancer, 2019, v. 144, n. 5, p. 1115, doi. 10.1002/ijc.31773
- By:
- Publication type:
- Article
CLCA2 epigenetic regulation by CTBP1, HDACs, ZEB1, EP300 and miR‐196b‐5p impacts prostate cancer cell adhesion and EMT in metabolic syndrome disease.
- Published in:
- International Journal of Cancer, 2018, v. 143, n. 4, p. 897, doi. 10.1002/ijc.31379
- By:
- Publication type:
- Article